全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 1485684-77-2 | 4-(2-Bromoethynyl)benzoic acid | C9H5BrO2 |
| 1486464-40-7 | 1-[[2-Hydroxy-3-[4-(2-methoxyethyl)phenoxy]propyl]-propan-2-ylamino]-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol hydrochloride | C27H41NO6.HCl |
| 1486464-41-8 | Terazosin dimer impurity dihydrochloride;2-[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine;dihydrochloride | C24H30Cl2N8O4 |
| 1486466-31-2 | (8S,9R,10S,11S,13S,14S,16S,17R)-4'-Chloro-5'-ethyl-9-fluoro-11-hydroxy-10,13,16-trimethylspiro[6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17,2'-furan]-3,3'-dione | C25H30ClFO4 |
| 1486470-12-5 | (1S,2S)-2-[[(1,1-Dimethylethoxy)carbonyl]amino]cyclopropanecarboxylic acid | C9H15NO4 |
| 1487316-54-0 | Tert-butyl cis-3,5-diaminopiperidine-1-carboxylate | C10H21N3O2 |
| 1489004-27-4 | (alphaE)-4-Chloro-alpha-[[[(1,1-dimethylethoxy)carbonyl](1-methylethyl)amino]methylene]benzeneacetic acid | C17H22ClNO4 |
| 1489389-18-5 | 5-[[4-[[(2R)-2-Morpholinylmethyl]amino]-5-(trifluoromethyl)-2-pyridinyl]amino]-2-pyrazinecarbonitrile | C16H16F3N7O |
| 1491158-62-3 | Fmoc-Lys(Pal-Glu-OtBu)-OH;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[[(4S)-4-(hexadecanoylamino)-5-[(2-methylpropan-2-yl)oxy]-5-oxopentanoyl]amino]hexanoic acid | C46H69N3O8 |
| 1493694-70-4 | trans-4-[[2-(Butylamino)-5-[5-(4-morpholinylmethyl)-2-pyridinyl]-4-pyrimidinyl]amino]cyclohexanol | C24H36N6O2 |
| 1493715-28-8 | 3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-9-(2-naphthalenyl)carbazole;9-naphthalen-2-yl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)carbazole | C28H26BNO2 |
| 1493764-08-1 | 2-(Butylamino)-4-[(trans-4-hydroxycyclohexyl)amino]-N-[[4-(1H-imidazol-1-yl)phenyl]methyl]-5-pyrimidinecarboxamide;UNC 2881 | C25H33N7O2 |
| 1494675-86-3 | N-(2-Hydroxyethyl)-1-[(6-methoxy-5-methylpyrimidin-4-yl)methyl]-6-methyl-1H-pyrrolo[3,2-b]pyridine-3-carboxamide | C18H21N5O3 |
| 1496510-51-0 | Relacorilant;[(4aR)-1-(4-fluorophenyl)-6-(1-methylpyrazol-4-yl)sulfonyl-4,5,7,8-tetrahydropyrazolo[3,4-g]isoquinolin-4a-yl]-[4-(trifluoromethyl)pyridin-2-yl]methanone | C27H22F4N6O3S |
| 1496536-69-6 | 4-Methoxyphenyl 3,4-O-(1-methylethylidene)-beta-D-galactopyranoside 2,6-bis(4-methylbenzoate) | C32H34O9 |
| 1496551-72-4 | Sofosbuvir Impurity 35;1-((2R,3R,4R,5R)-3-chloro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione | C10H13ClN2O5 |
| 1496552-16-9 | Sofosbuvir Impurity 50;Sofosbuvir impurity A;propan-2-yl (2R)-2-[[[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate | C22H29FN3O9P |
| 1496552-28-3 | N-[[P(S),2'R]-2'-Deoxy-2'-fluoro-2'-methyl-P-phenyl-5'-uridylyl]-D-alanine 1-methylethyl ester | C22H29FN3O9P |
| 1496581-76-0 | 2-[[6-(3,3-Difluoro-1-pyrrolidinyl)-4-[1-(3-oxetanyl)-4-piperidinyl]-2-pyridinyl]amino]-4-pyridinecarbonitrile | C23H26F2N6O |
| 1496637-05-8 | (11bS)-4-Hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 4-oxide | C56H37O4P |
| 1496997-41-1 | 2-(2,6-Dioxopiperidin-3-yl)-5,6-difluoroisoindoline-1,3-dione | C13H8F2N2O4 |
| 1499167-72-4 | Azilsartan Impurity 8;methyl 3-[[4-[2-[(E)-(hydroxyhydrazinylidene)methyl]phenyl]phenyl]methyl]-2-oxo-1H-benzimidazole-4-carboxylate | C23H20N4O4 |
| 1499193-60-0 | 2-Bromo-9,9-difluoro-7-iodo-9H-fluorene | C13H6BrF2I |
| 1499193-67-7 | (6S)-6-[5-[7-[2-(1R,3S,4S)-2-Azabicyclo[2.2.1]hept-3-yl-1H-benzimidazol-6-yl]-9,9-difluoro-9H-fluoren-2-yl]-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane hydrochloride (1:4) | C35H32F2N6.4(HCl) |
| 1500106-31-9 | potassium (T-4)-trifluoro-1-propyn-1-yl-Borate | C3H3BF3.K |
| 1502816-23-0 | N-Methyl-4-(phenylmethoxy)-1-piperidineethanamine | C15H24N2O |
| 1503408-77-2 | 6-Chloro-3,4-dimethylpyridin-2-amine | C7H9ClN2 |
| 1504965-88-1 | 5-Amino-2-fluoro-4-methylbenzoic acid methyl ester;Methyl 5-amino-2-fluoro-4-methylbenzoate | C9H10FNO2 |
| 1505453-59-7 | (4S)-6-(4-Chlorophenyl)-1-methyl-8-(1-methyl-1H-pyrazol-4-yl)-4H-isoxazolo[5,4-d][2]benzazepine-4-acetamide | C24H20ClN5O2 |
| 1505641-47-3 | 3-Bromo-5,6-dihydro-8H-imidazo[2,1-c][1,4]oxazine¡ãC | C6H7BrN2O |
| 1505662-44-1 | 3-Acetyl-4-fluorobenzoic acid | C9H7FO3 |
| 1506066-94-9 | Octahydro-5-(phenylmethyl)-1H-pyrrolo[3,2-c]pyridine | C14H20N2 |
| 1507370-20-8 | N1,N2-Bis[[4-(2-pyridinyl)phenyl]methyl]-1,2-ethanediamine | C26H26N4 |
| 1507370-40-2 | N1,N2-Bis[[4-(2-thiazolyl)phenyl]methyl]-1,2-ethanediamine | C22H22N4S2 |
| 1507403-85-1 | 4MetBuXPhos Pd G3;Methanesulfonato(2-di-t-butylphosphino-3,4,5,6-tetramethyl-2',4',6'-tri-i-propylbiphenyl)(2'-amino-1,1'-biphenyl-2-yl)palladium(II) | C46H66NO3PPdS |
| 1507404-60-5 | Methanesulfonato[2-(Di-1-adamantylphosphino)-2',4',6'-triisopropyl-3,6-dimethoxybiphenyl][2-(2'-amino-1,1'-biphenyl)]palladium(II);1-adamantyl-(2-adamantyl)-[3,6-dimethoxy-2-[2,4,6-tri(propan-2-yl)phenyl]phenyl]phosphanium palladium(2+) (2-phenylphenyl)azanide;trifluoromethanesulfonic acid | C56H71F3NO5PPdS |
| 1508250-71-2 | Nazartinib;N-[7-Chloro-1-[(3R)-1-[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]hexahydro-1H-azepin-3-yl]-1H-benzimidazol-2-yl]-2-methyl-4-pyridinecarboxamide; EGF 816 | C26H31ClN6O2 |
| 1508261-86-6 | 2-Methyl-L-proline hydrochloride;(2S)-2-methylpyrrolidine-2-carboxylic acid;hydrochloride | C6H11NO2.HCl |
| 1508892-33-8 | alpha,3-Dihydroxybenzenepropanoic acid methyl ester | C10H12O4 |
| 1510820-22-0 | Ezetimibe Dehydroxy Impurity;(3R,4S)-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)propyl]-4-(4-hydroxyphenyl)azetidin-2-one | C24H21F2NO2 |
| 1510821-28-9 | N-[2-(2-Ethoxyphenoxy)ethyl]-4-methoxy-alpha-methylbenzeneethanamine | C20H27NO3 |
| 1513253-45-6 | N-(2,3-dihydro-1,4-benzodioxin-6-yl)-1H-imidazol-2-amine | C11H11N3O2 |
| 1515856-92-4 | 2-[(3S)-3-(2-Pyridinylmethoxy)-1-pyrrolidinyl]-5-(trifluoromethyl)benzoic acid | C18H17F3N2O3 |
| 1516140-99-0 | Tetrahydro-2H-pyran-4-sulfinic acid sodium salt (1:1) | C5H9O3S.Na |
| 1516895-53-6 | rel-2-[(1R,2R)-2-(5,8-Dimethyl[1,2,4]triazolo[1,5-a]pyrazin-2-yl)cyclopropyl]-3-methylimidazo[2,1-f][1,6]naphthyridine | C21H19N7 |
| 1517576-71-4 | 6-Bromo-2,3-difluorophenylacetonitrile | C8H4BrF2N |
| 1517611-20-9 | 2-Bromo-3,4-difluorobenzonitrile | C7H2BrF2N |
| 1522098-73-2 | 4-(Hydroxymethyl)-2-azabicyclo[2.1.1]hexane-1-carboxylic acid | C7H11NO3 |
| 1522718-34-8 | 1-Methyl-3-(3-nitrophenyl)imidazolidin-2-one | C10H11N3O3 |
| 1523406-39-4 | (8S)-9-[(5-Chloro-3-pyridinyl)methyl]-6,7,8,9-tetrahydro-2-[(3R)-3-methyl-4-morpholinyl]-8-(trifluoromethyl)-4H-pyrimido[1,2-a]pyrimidin-4-one;SAR 405 | C19H21ClF3N5O2 |